The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Breast Cancer Screening Tests-Global Market Insights and Sales Trends 2024
Synopsis
Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
The global Breast Cancer Screening Tests market size is expected to reach US$ 58 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Screening Tests in various end use industries. The expanding demands from the Research Labs, Cancer Institutes, Diagnostic Centers and Others, are propelling Breast Cancer Screening Tests market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at % CAGR for the next seven-year period.
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Screening Tests covered in this report include Hologic, Siemens Healthcare, Carestream Health, Philips Healthcare, Shimadzu Corporation, Canon Medical Systems, Hitachi Medical Corporation, Esaote and Agilent Technologies, etc.
The global Breast Cancer Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hologic
Siemens Healthcare
Carestream Health
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Hitachi Medical Corporation
Esaote
Agilent Technologies
Global Breast Cancer Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Screening Tests market, Segment by Type:
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
Global Breast Cancer Screening Tests market, by Application
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the signs & symptoms of breast cancer. Breast cancer screening does not prevent the disease. However, detection in early stage increases the chances of recovery from the disease. Breast cancer screening tests are offered to women aged between 50-70 years as they are more prone to the disease.
The global Breast Cancer Screening Tests market size is expected to reach US$ 58 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Screening Tests in various end use industries. The expanding demands from the Research Labs, Cancer Institutes, Diagnostic Centers and Others, are propelling Breast Cancer Screening Tests market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at % CAGR for the next seven-year period.
Breast Cancer Screening Tests Market is primarily driven by a few key factors such as the patient awareness regarding rising healthcare concerns, increasing research for detection of various types of cancers, and prevention of disease. In addition to this, Breast Cancer Screening Tests Market also observes significant growth due to different government initiatives and public awareness campaigns.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Screening Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Screening Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Screening Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Screening Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Screening Tests covered in this report include Hologic, Siemens Healthcare, Carestream Health, Philips Healthcare, Shimadzu Corporation, Canon Medical Systems, Hitachi Medical Corporation, Esaote and Agilent Technologies, etc.
The global Breast Cancer Screening Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hologic
Siemens Healthcare
Carestream Health
Philips Healthcare
Shimadzu Corporation
Canon Medical Systems
Hitachi Medical Corporation
Esaote
Agilent Technologies
Global Breast Cancer Screening Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Screening Tests market, Segment by Type:
Physical Exam
Laboratory Tests
Imaging Tests
Genetic Tests
Global Breast Cancer Screening Tests market, by Application
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Screening Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Breast Cancer Screening Tests
1.1 Breast Cancer Screening Tests Market Overview
1.1.1 Breast Cancer Screening Tests Product Scope
1.1.2 Breast Cancer Screening Tests Market Status and Outlook
1.2 Global Breast Cancer Screening Tests Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Breast Cancer Screening Tests Market Size by Region (2018-2029)
1.4 Global Breast Cancer Screening Tests Historic Market Size by Region (2018-2023)
1.5 Global Breast Cancer Screening Tests Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Breast Cancer Screening Tests Market Size (2018-2029)
1.6.1 North America Breast Cancer Screening Tests Market Size (2018-2029)
1.6.2 Europe Breast Cancer Screening Tests Market Size (2018-2029)
1.6.3 Asia-Pacific Breast Cancer Screening Tests Market Size (2018-2029)
1.6.4 Latin America Breast Cancer Screening Tests Market Size (2018-2029)
1.6.5 Middle East & Africa Breast Cancer Screening Tests Market Size (2018-2029)
2 Breast Cancer Screening Tests Market by Type
2.1 Introduction
2.1.1 Physical Exam
2.1.2 Laboratory Tests
2.1.3 Imaging Tests
2.1.4 Genetic Tests
2.2 Global Breast Cancer Screening Tests Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Breast Cancer Screening Tests Historic Market Size by Type (2018-2023)
2.2.2 Global Breast Cancer Screening Tests Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Breast Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Breast Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Breast Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Breast Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Breast Cancer Screening Tests Revenue Breakdown by Type (2018-2029)
3 Breast Cancer Screening Tests Market Overview by Application
3.1 Introduction
3.1.1 Research Labs
3.1.2 Cancer Institutes
3.1.3 Diagnostic Centers
3.1.4 Others
3.2 Global Breast Cancer Screening Tests Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Breast Cancer Screening Tests Historic Market Size by Application (2018-2023)
3.2.2 Global Breast Cancer Screening Tests Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Breast Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Breast Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Breast Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Breast Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Breast Cancer Screening Tests Revenue Breakdown by Application (2018-2029)
4 Breast Cancer Screening Tests Competition Analysis by Players
4.1 Global Breast Cancer Screening Tests Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Screening Tests as of 2022)
4.3 Date of Key Players Enter into Breast Cancer Screening Tests Market
4.4 Global Top Players Breast Cancer Screening Tests Headquarters and Area Served
4.5 Key Players Breast Cancer Screening Tests Product Solution and Service
4.6 Competitive Status
4.6.1 Breast Cancer Screening Tests Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Hologic
5.1.1 Hologic Profile
5.1.2 Hologic Main Business
5.1.3 Hologic Breast Cancer Screening Tests Products, Services and Solutions
5.1.4 Hologic Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.1.5 Hologic Recent Developments
5.2 Siemens Healthcare
5.2.1 Siemens Healthcare Profile
5.2.2 Siemens Healthcare Main Business
5.2.3 Siemens Healthcare Breast Cancer Screening Tests Products, Services and Solutions
5.2.4 Siemens Healthcare Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Healthcare Recent Developments
5.3 Carestream Health
5.3.1 Carestream Health Profile
5.3.2 Carestream Health Main Business
5.3.3 Carestream Health Breast Cancer Screening Tests Products, Services and Solutions
5.3.4 Carestream Health Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.3.5 Philips Healthcare Recent Developments
5.4 Philips Healthcare
5.4.1 Philips Healthcare Profile
5.4.2 Philips Healthcare Main Business
5.4.3 Philips Healthcare Breast Cancer Screening Tests Products, Services and Solutions
5.4.4 Philips Healthcare Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.4.5 Philips Healthcare Recent Developments
5.5 Shimadzu Corporation
5.5.1 Shimadzu Corporation Profile
5.5.2 Shimadzu Corporation Main Business
5.5.3 Shimadzu Corporation Breast Cancer Screening Tests Products, Services and Solutions
5.5.4 Shimadzu Corporation Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.5.5 Shimadzu Corporation Recent Developments
5.6 Canon Medical Systems
5.6.1 Canon Medical Systems Profile
5.6.2 Canon Medical Systems Main Business
5.6.3 Canon Medical Systems Breast Cancer Screening Tests Products, Services and Solutions
5.6.4 Canon Medical Systems Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.6.5 Canon Medical Systems Recent Developments
5.7 Hitachi Medical Corporation
5.7.1 Hitachi Medical Corporation Profile
5.7.2 Hitachi Medical Corporation Main Business
5.7.3 Hitachi Medical Corporation Breast Cancer Screening Tests Products, Services and Solutions
5.7.4 Hitachi Medical Corporation Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.7.5 Hitachi Medical Corporation Recent Developments
5.8 Esaote
5.8.1 Esaote Profile
5.8.2 Esaote Main Business
5.8.3 Esaote Breast Cancer Screening Tests Products, Services and Solutions
5.8.4 Esaote Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.8.5 Esaote Recent Developments
5.9 Agilent Technologies
5.9.1 Agilent Technologies Profile
5.9.2 Agilent Technologies Main Business
5.9.3 Agilent Technologies Breast Cancer Screening Tests Products, Services and Solutions
5.9.4 Agilent Technologies Breast Cancer Screening Tests Revenue (US$ Million) & (2018-2023)
5.9.5 Agilent Technologies Recent Developments
6 North America
6.1 North America Breast Cancer Screening Tests Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Breast Cancer Screening Tests Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Screening Tests Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Breast Cancer Screening Tests Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Screening Tests Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Breast Cancer Screening Tests Market Dynamics
11.1 Breast Cancer Screening Tests Industry Trends
11.2 Breast Cancer Screening Tests Market Drivers
11.3 Breast Cancer Screening Tests Market Challenges
11.4 Breast Cancer Screening Tests Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
